EMEA (Europe, Middle East and Africa) Rituximab Market Report 2018

January 2018 | 109 pages | ID: E244E93FA99EN
QYResearch

Abstracts

In this report, the EMEA Rituximab market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Rituximab for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Rituximab market competition by top manufacturers/players, with Rituximab sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Roche

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• 10ml
• 50ml

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hematological Cancers
• Autoimmune Diseases
• Organ Transplants

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Rituximab Market Report 2017

1 RITUXIMAB OVERVIEW

1.1 Product Overview and Scope of Rituximab
1.2 Classification of Rituximab
  1.2.1 EMEA Rituximab Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Rituximab Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 10ml
  1.2.4 50ml
1.3 EMEA Rituximab Market by Application/End Users
  1.3.1 EMEA Rituximab Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hematological Cancers
  1.3.3 Autoimmune Diseases
  1.3.4 Organ Transplants
1.4 EMEA Rituximab Market by Region
  1.4.1 EMEA Rituximab Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Rituximab (2012-2022)
  1.5.1 EMEA Rituximab Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Rituximab Revenue and Growth Rate (2012-2022)

2 EMEA RITUXIMAB COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Rituximab Market Competition by Players/Manufacturers
  2.1.1 EMEA Rituximab Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Rituximab Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Rituximab Sale Price by Players (2012-2017)
2.2 EMEA Rituximab (Volume and Value) by Type/Product Category
  2.2.1 EMEA Rituximab Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Rituximab Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Rituximab Sale Price by Type (2012-2017)
2.3 EMEA Rituximab (Volume) by Application
2.4 EMEA Rituximab (Volume and Value) by Region
  2.4.1 EMEA Rituximab Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Rituximab Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Rituximab Sales Price by Region (2012-2017)

3 EUROPE RITUXIMAB (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Rituximab Sales and Value (2012-2017)
  3.1.1 Europe Rituximab Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Rituximab Revenue and Growth Rate (2012-2017)
3.2 Europe Rituximab Sales and Market Share by Type
3.3 Europe Rituximab Sales and Market Share by Application
3.4 Europe Rituximab Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Rituximab Sales Volume by Countries (2012-2017)
  3.4.2 Europe Rituximab Revenue by Countries (2012-2017)
  3.4.3 Germany Rituximab Sales and Growth Rate (2012-2017)
  3.4.4 France Rituximab Sales and Growth Rate (2012-2017)
  3.4.5 UK Rituximab Sales and Growth Rate (2012-2017)
  3.4.6 Russia Rituximab Sales and Growth Rate (2012-2017)
  3.4.7 Italy Rituximab Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Rituximab Sales and Growth Rate (2012-2017)

4 MIDDLE EAST RITUXIMAB (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Rituximab Sales and Value (2012-2017)
  4.1.1 Middle East Rituximab Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Rituximab Revenue and Growth Rate (2012-2017)
4.2 Middle East Rituximab Sales and Market Share by Type
4.3 Middle East Rituximab Sales and Market Share by Application
4.4 Middle East Rituximab Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Rituximab Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Rituximab Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Rituximab Sales and Growth Rate (2012-2017)
  4.4.4 Israel Rituximab Sales and Growth Rate (2012-2017)
  4.4.5 UAE Rituximab Sales and Growth Rate (2012-2017)
  4.4.6 Iran Rituximab Sales and Growth Rate (2012-2017)

5 AFRICA RITUXIMAB (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Rituximab Sales and Value (2012-2017)
  5.1.1 Africa Rituximab Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Rituximab Revenue and Growth Rate (2012-2017)
5.2 Africa Rituximab Sales and Market Share by Type
5.3 Africa Rituximab Sales and Market Share by Application
5.4 Africa Rituximab Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Rituximab Sales Volume by Countries (2012-2017)
  5.4.2 Africa Rituximab Revenue by Countries (2012-2017)
  5.4.3 South Africa Rituximab Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Rituximab Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Rituximab Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Rituximab Sales and Growth Rate (2012-2017)

6 EMEA RITUXIMAB MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Roche
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Rituximab Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Roche Rituximab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview

7 RITUXIMAB MANUFACTURING COST ANALYSIS

7.1 Rituximab Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Rituximab

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Rituximab Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Rituximab Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA RITUXIMAB MARKET FORECAST (2017-2022)

11.1 EMEA Rituximab Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Rituximab Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Rituximab Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Rituximab Price and Trend Forecast (2017-2022)
11.2 EMEA Rituximab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Rituximab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Rituximab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Rituximab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Rituximab Sales Forecast by Type (2017-2022)
11.7 EMEA Rituximab Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Rituximab
Figure EMEA Rituximab Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Rituximab Sales Volume Market Share by Type (Product Category) in 2016
Figure 10ml Product Picture
Figure 50ml Product Picture
Figure EMEA Rituximab Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Rituximab by Application in 2016
Figure Hematological Cancers Examples
Table Key Downstream Customer in Hematological Cancers
Figure Autoimmune Diseases Examples
Table Key Downstream Customer in Autoimmune Diseases
Figure Organ Transplants Examples
Table Key Downstream Customer in Organ Transplants
Figure EMEA Rituximab Market Size (Million USD) by Region (2012-2022)
Figure Europe Rituximab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Rituximab Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Rituximab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Rituximab Revenue (Million USD) Status and Forecast by Countries
Figure Africa Rituximab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Rituximab Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Rituximab Sales Volume and Growth Rate (2012-2022)
Figure EMEA Rituximab Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Rituximab Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Rituximab Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Rituximab Sales Share by Players (2012-2017)
Figure 2016 Rituximab Sales Share by Players
Figure 2017 Rituximab Sales Share by Players
Figure EMEA Rituximab Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Rituximab Revenue (Million USD) by Players (2012-2017)
Table EMEA Rituximab Revenue Share by Players (2012-2017)
Table 2016 EMEA Rituximab Revenue Share by Players
Table 2017 EMEA Rituximab Revenue Share by Players
Table EMEA Rituximab Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Rituximab Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Rituximab Sales Share by Type (2012-2017)
Figure Sales Market Share of Rituximab by Type (2012-2017)
Figure EMEA Rituximab Sales Market Share by Type (2012-2017)
Table EMEA Rituximab Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Rituximab Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Rituximab by Type in 2016
Table EMEA Rituximab Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Rituximab Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Rituximab Sales Share by Application (2012-2017)
Figure Sales Market Share of Rituximab by Application (2012-2017)
Figure EMEA Rituximab Sales Market Share by Application in 2016
Table EMEA Rituximab Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Rituximab Sales Share by Region (2012-2017)
Figure Sales Market Share of Rituximab by Region (2012-2017)
Figure EMEA Rituximab Sales Market Share in 2016
Table EMEA Rituximab Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Rituximab Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Rituximab by Region (2012-2017)
Figure EMEA Rituximab Revenue Market Share Regions in 2016
Table EMEA Rituximab Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Rituximab Revenue and Growth Rate (2012-2017)
Table Europe Rituximab Sales (K Units) by Type (2012-2017)
Table Europe Rituximab Market Share by Type (2012-2017)
Figure Europe Rituximab Market Share by Type in 2016
Table Europe Rituximab Sales (K Units) by Application (2012-2017)
Table Europe Rituximab Market Share by Application (2012-2017)
Figure Europe Rituximab Market Share by Application in 2016
Table Europe Rituximab Sales (K Units) by Countries (2012-2017)
Table Europe Rituximab Sales Market Share by Countries (2012-2017)
Figure Europe Rituximab Sales Market Share by Countries (2012-2017)
Figure Europe Rituximab Sales Market Share by Countries in 2016
Table Europe Rituximab Revenue (Million USD) by Countries (2012-2017)
Table Europe Rituximab Revenue Market Share by Countries (2012-2017)
Figure Europe Rituximab Revenue Market Share by Countries (2012-2017)
Figure Europe Rituximab Revenue Market Share by Countries in 2016
Figure Germany Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure France Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure UK Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Rituximab Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Rituximab Sales (K Units) by Type (2012-2017)
Table Middle East Rituximab Market Share by Type (2012-2017)
Figure Middle East Rituximab Market Share by Type (2012-2017)
Table Middle East Rituximab Sales (K Units) by Applications (2012-2017)
Table Middle East Rituximab Market Share by Applications (2012-2017)
Figure Middle East Rituximab Sales Market Share by Application in 2016
Table Middle East Rituximab Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Rituximab Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Rituximab Sales Volume Market Share by Countries in 2016
Table Middle East Rituximab Revenue (Million USD) by Countries (2012-2017)
Table Middle East Rituximab Revenue Market Share by Countries (2012-2017)
Figure Middle East Rituximab Revenue Market Share by Countries (2012-2017)
Figure Middle East Rituximab Revenue Market Share by Countries in 2016
Figure Saudi Arabia Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Rituximab Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Rituximab Sales (K Units) by Type (2012-2017)
Table Africa Rituximab Sales Market Share by Type (2012-2017)
Figure Africa Rituximab Sales Market Share by Type (2012-2017)
Figure Africa Rituximab Sales Market Share by Type in 2016
Table Africa Rituximab Sales (K Units) by Application (2012-2017)
Table Africa Rituximab Sales Market Share by Application (2012-2017)
Figure Africa Rituximab Sales Market Share by Application (2012-2017)
Table Africa Rituximab Sales Volume (K Units) by Countries (2012-2017)
Table Africa Rituximab Sales Market Share by Countries (2012-2017)
Figure Africa Rituximab Sales Market Share by Countries (2012-2017)
Figure Africa Rituximab Sales Market Share by Countries in 2016
Table Africa Rituximab Revenue (Million USD) by Countries (2012-2017)
Table Africa Rituximab Revenue Market Share by Countries (2012-2017)
Figure Africa Rituximab Revenue Market Share by Countries (2012-2017)
Figure Africa Rituximab Revenue Market Share by Countries in 2016
Figure South Africa Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Rituximab Sales (K Units) and Growth Rate (2012-2017)
Table Roche Rituximab Basic Information List
Table Roche Rituximab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Rituximab Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Rituximab Sales Market Share in EMEA (2012-2017)
Figure Roche Rituximab Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rituximab
Figure Manufacturing Process Analysis of Rituximab
Figure Rituximab Industrial Chain Analysis
Table Raw Materials Sources of Rituximab Major Manufacturers in 2016
Table Major Buyers of Rituximab
Table Distributors/Traders List
Figure EMEA Rituximab Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Rituximab Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Rituximab Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Rituximab Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Rituximab Sales Market Share Forecast by Region (2017-2022)
Table EMEA Rituximab Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Rituximab Revenue Market Share Forecast by Region (2017-2022)
Table Europe Rituximab Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Rituximab Sales Market Share Forecast by Countries (2017-2022)
Table Europe Rituximab Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Rituximab Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Rituximab Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Rituximab Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Rituximab Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Rituximab Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Rituximab Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Rituximab Sales Market Share Forecast by Countries (2017-2022)
Table Africa Rituximab Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Rituximab Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Rituximab Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Rituximab Sales Market Share Forecast by Type (2017-2022)
Table EMEA Rituximab Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Rituximab Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources